Evidence map›Paper›PMID 40805179›Full record

ArticleCancers2025

Chemotherapy (Etoposide)-Induced Intermingling of Heterochromatin and Euchromatin Compartments in Senescent PA-1 Embryonal Carcinoma Cells.

Marc Bayer, Jaroslava Zajakina, Myriam Schäfer, Kristine Salmina, Felikss Rumnieks, Juris Jansons, Felix Bestvater, Reet Kurg, Jekaterina Erenpreisa, Michael Hausmann

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marc BayerKirchhoff-Institute for Physics, Heidelberg University, Im Neuenheimer Feld 227, 69120 Heidelberg, Germany.ORCID 0009-0009-7752-6215
Jaroslava ZajakinaKirchhoff-Institute for Physics, Heidelberg University, Im Neuenheimer Feld 227, 69120 Heidelberg, Germany.
Myriam SchäferKirchhoff-Institute for Physics, Heidelberg University, Im Neuenheimer Feld 227, 69120 Heidelberg, Germany.
Kristine SalminaLatvian Biomedical Research and Study Centre, Rātsupītes iela 1, LV-1067 Rīga, Latvia.
Felikss RumnieksLatvian Biomedical Research and Study Centre, Rātsupītes iela 1, LV-1067 Rīga, Latvia.ORCID 0000-0003-3745-3575
Juris JansonsLatvian Biomedical Research and Study Centre, Rātsupītes iela 1, LV-1067 Rīga, Latvia.ORCID 0000-0003-0845-4392
Felix BestvaterGerman Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Reet KurgInstitute of Technology, University of Tartu, Nooruse 1, 50411 Tartu, Estonia.ORCID 0000-0001-7188-9693
Jekaterina ErenpreisaLatvian Biomedical Research and Study Centre, Rātsupītes iela 1, LV-1067 Rīga, Latvia.ORCID 0000-0002-2870-7775
Michael HausmannKirchhoff-Institute for Physics, Heidelberg University, Im Neuenheimer Feld 227, 69120 Heidelberg, Germany.ORCID 0000-0001-9430-1987

Funding

Baltic-German University Liaison lzp-2022/1-0114
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cell-fatechromatin re-organization in tumor cellsDNA damage by etoposidesenescencesingle-molecule localization microscopystatistical and topological data evaluationstemness self-renewal

Identifiers

PMID40805179
PMCPMC12345858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.